Glaucoma, Open-Angle, Ocular Hypertension
Conditions
Keywords
Glaucoma, Open-Angle Ocular Hypertension Risk factors Canadian
Brief summary
This descriptive, non-interventional study will collect information on the presence of risk factors in newly diagnosed ocular hypertension and open-angle glaucoma patients in Canada.
Interventions
This study is collecting information on the presence of risk factors in new diagnosed OH and OAG patients in Canada.
Sponsors
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Subjects diagnosed at study visit or within 3 months of visit with OH * OAG (to include POAG, NTG, pigmentary and pseudoexfoliation glaucoma)
Exclusion criteria
* No prior treatment for OH or OAG * No prior ocular surgery or history of ocular trauma
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To describe the presence and distribution of risk factors in subjects diagnosed with OH or OAG stratified according to geographic distribution in a Canadian population in the ophthalmologist practice. | duration of study |
Secondary
| Measure | Time frame |
|---|---|
| To describe the severity of disease at the time of diagnosis and to determine if there is a correlation between risk factors, or number of risk factors, and the severity of disease at presentation. | duration of study |
Countries
Canada
Outcome results
None listed